Physician profile
Amber Watters
NPI 1134625825
$4,041.91
in general payments reported to CMS, 2019-2025
17 companies · $1,885 in 2025
The $1,885 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.32 · 2020: $13.36 · 2022: $41.46 · 2023: $408 · 2024: $1,677 · 2025: $1,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,247 · Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,247.42 |
| Food and Beverage | $722.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,155.82 | 2024-2025 | |
| Astellas Pharma US INC | $243.46 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $130.97 | 2022-2023 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $94.17 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $86.13 | 2023-2025 | Myfembree |
| Biogen, INC. | $70.88 | 2025 | Zurzuvae |
| Millicent US INC | $67.38 | 2025 | Intrarosa, Femring |
| Boston Scientific Corporation | $30.68 | 2019-2020 | |
| Daiichi Sankyo INC. | $27.34 | 2024 | Injectafer |
| Coopersurgical, INC. | $23.31 | 2024 | Paragard T 380a |
| Heron Therapeutics, INC. | $20.99 | 2023 | Zynrelef |
| Lilly USA, LLC | $17.90 | 2025 | Zepbound |
| Pfizer INC. | $17.44 | 2023 | |
| Ethicon US, LLC | $16.47 | 2025 | Harmonic |
| Optumhealth Care Solutions, LLC | $14.92 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $14.39 | 2023 | Bd Onclarity |
| Meditrina | $9.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Watters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.